Skip to main content
. 2021 Jul 10;13(7):477. doi: 10.3390/toxins13070477
15-ADON 15-acetyldeoxynivalenol
3-ADON 3-acetyldeoxynivalenol
amyloid beta
ACN acetonitrile
AD Alzheimer´s disease
AFB1 aflatoxin B1
AFB2 aflatoxin B2
AFG1 aflatoxin G1
AFG2 aflatoxin G2
AFM1 aflatoxin M1
CIRS chronic inflammatory response syndrome
CNT control
DAS diacetoxyscirpenol
DOM-1 deepoxy-deoxynivalenol
DON deoxynivalenol
FUS-X fusarenon-X
GDS Global Deterioration Scale
HBM human biomonitoring
HY Hoehn and Yahr
LC liquid chromatography
LC-MS/MS liquid chromatography coupled to mass spectrometry in tandem
LOD limit of detection
LOQ limit of quantification
NEO neosolaniol
NIV nivalenol
OTA ochratoxin A
OTA-d5 ochratoxin A-(phenyl-d5)
OTB ochratoxin B
PD Parkinson´s disease
q transition of qualification
Q transition of quantification
QqQ triple quadrupole
RE relative error of the mean
SD standard deviation
STER sterigmatocystin
ZEA zearalenone
HHS Vulnerability Disclosure